# Study of Oral Metronidazole on Postoperative Chemotherapy in Colorectal Cancer

> **NCT04264676** · PHASE2 · UNKNOWN · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 294 (estimated)

## Conditions studied

- Colorectal Cancer Stage II
- Colorectal Cancer Stage III

## Interventions

- **DRUG:** Metronidazole Oral Tablet
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04264676
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-31
- **Primary completion:** 2023-03
- **Final completion:** 2025-03
- **Target enrollment:** 294 (ESTIMATED)
- **Last updated:** 2020-11-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04264676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04264676, "Study of Oral Metronidazole on Postoperative Chemotherapy in Colorectal Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04264676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*